Efficacy of treatment with chimeric monoclonal antibody (Infliximab) to tumor necrosis factor-α for Crohn's disease in Japan: Evaluation by rapid turnover proteins, and radiologic and endoscopic findings

Hitoshi Asakura, Tsuneyoshi Yao, Toshiyuki Matsui, Kazutaka Koganei, Tsuneo Fukushima, Masakazu Takazoe, Reiko Hobara, Hiroshi Nakano, Shouzou Okamura, Kei Matsueda, Hiroshi Kashida, Kazuya Makiyama, Nobuo Hiwatashi, Kazuhiro Kashiwagi, Toshifumi Hibi

研究成果: Article

26 引用 (Scopus)

フィンガープリント Efficacy of treatment with chimeric monoclonal antibody (Infliximab) to tumor necrosis factor-α for Crohn's disease in Japan: Evaluation by rapid turnover proteins, and radiologic and endoscopic findings' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

Medicine & Life Sciences